马超,安志杰,曾玫,王富珍,李艺星,郝利新,温宁,张国民,余文周,李克莉,曹雷,郑徽,姜玉武,李军宏,王亚敏,王华庆,尹遵栋,冯子健

• 1:中国疾病预防控制中心国家免疫规划技术工作组
• 2:复旦大学附属儿科医院
• 3:北京大学第一医院

摘要(Abstract)：

根据预防接种工作需要并受国家卫生健康委员会疾病预防控制局委托,2019-2020年中国疾病预防控制中心国家免疫规划技术工作组在《国家免疫规划疫苗儿童免疫程序及说明(2016年版)》基础上,整合相关疫苗和疾病防控最新证据,组织对该文件进行了修订。经国家免疫规划专家咨询委员会审议后,国家卫生健康委员会于2021年2月印发了《国家免疫规划疫苗儿童免疫程序及说明(2021年版)》。本文对该新版文件的主要内容及其修订情况进行了解析。

关键词(KeyWords)： 国家免疫规划;疫苗;免疫程序;儿童;解析

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 马超,安志杰,曾玫,王富珍,李艺星,郝利新,温宁,张国民,余文周,李克莉,曹雷,郑徽,姜玉武,李军宏,王亚敏,王华庆,尹遵栋,冯子健

参考文献(References)：

• [1] 迮文远，刁连东，徐爱强.计划免疫学[J].第2版.上海：上海科学技术文献出版社，2001:62.
• [2] 国家卫生健康委.关于印发国家免疫规划疫苗儿童免疫程序及说明(2021年版)的通知[Z].2021-02-23.
• [3] 卫生部.关于印发《预防接种工作规范》的通知[Z].2005-09-20.
• [4] 卫生部.关于印发《扩大国家免疫规划实施方案》的通知[Z].2007-12-29.
• [5] 国家卫生计生委办公厅.关于印发国家免疫规划儿童免疫程序及说明(2016年版)的通知[Z].2016-12-06.
• [6] EZEANOLUE E,HARRIMAN K,HUNTER P,et al.General best practice guidelines for immunization[EB/OL].(2020-11-20) [2021-03-03].https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html.
• [7] 朱建慧，黄巍，王筱颖，等.婴儿疫苗不同接种部位的安全性观察[J].浙江预防医学，2012,24(12):20-21+26.
• [8] WHO.WHO recommendations for routine immunization-summary tables[EB/OL].(2020-09-19) [2021-03-03].https://www.who.int/immunization/policy/immunization_tables/en.
• [9] 王陇德.预防接种实践与管理[J].北京：人民卫生出版社，2006:47-48.
• [10] 潘会明，严毅，王蕾.关于计免疫苗同时接种及其相关问题的探讨和建议[J].中国初级卫生保健，2013,27(12):73-75.
• [11] 张世英.关于一、二类疫苗不能同时接种规定的理性思考[J].中国公共卫生管理，2011,27(2):134-135.
• [12] 国家卫生健康委办公厅.关于印发非免疫规划疫苗使用指导原则(2020年版)的通知[Z].2020-12-07.
• [13] 国家食品药品监督管理局.关于印发化学药品和生物制品说明书规范细则的通知[Z].2006-05-10.
• [14] 国家药典委员会.中华人民共和国药典2015年版三部[M].北京：中国医药科技出版社，2015.
• [15] WHO.Hepatitis B vaccines:WHO position paper-July 2017[J].Weekly Epidemiological Record,2017,92(27):369-392.
• [16] 薄涛，夏跃伟，黎江，等.湖南省9所医院早产儿卡介苗及乙肝疫苗接种情况及未接种原因分析[J].现代生物医学进展，2018,18(22):4252-4255.
• [17] BADURDEEN S,MARSHALL A,DAISH H,et al.Safety and immunogenicity of early Bacillus Calmette-Guerin vaccination in infants who are preterm and/or have low birth weights:a systematic review and meta-analysis[J].JAMA Pediatrics,2019,173(1):75-85.
• [18] HIRD TR,GRASSLY NC.Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge[J].PLoS Pathogens,2017,8(4):e1002599.
• [19] SIMASATHIEN S,MIGASENA S,BEUVERY C,et al.Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants[J].Scandinavian Journal of Infectious Diseases,1994,26(6):731-738.
• [20] PLOTKIN SA,ORENSTEIN WA,PAUL A,et al.Vaccines[M].6th edition.Philadelphia:Elsevier,2008:579.
• [21] MA C,LIU Y,TANG J,et al.Assessment of mumps-containing vaccine effectiveness during an outbreak:importance to introduce the 2-dose schedule for China[J].Human Vaccines & Immunotherapeutics,2018,14(6):1392-1397.
• [22] DEMICHELI V,JEFFERSON T,DEBALINI MG,et al.Vaccines for measles,mumps and rubella in children[J].The Cochrane Database of Systematic Reviews,2005,(4):004407.
• [23] CASTILLA J,GARCIA CENOZ M,ARRIAZU M,et al.Effectiveness of Jeryl Lynn-containing vaccine in Spanish children[J].Vaccine,2009,27(15):2089-2093.
• [24] Anon.Mumps virus vaccines[J].Weekly Epidemiological Record,2007,82(7):51-60.
• [25] GALAZKA AM,ROBERTSON SE,KRAIGHER A.Mumps and mumps vaccine:a global review[J].Bulletin of the World Health Organization,1999,77(1):3-14.
• [26] 马超，郝利新，苏琪茹，等.世界卫生组织194个成员国麻疹、流行性腮腺炎、风疹减毒活疫苗常规免疫程序、报告接种率与发病水平现状分析[J].中国疫苗和免疫，2015,21(3):241-247+254.
• [27] HE H,CHEN E,CHEN H,et al.Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children[J].Vaccine,2014,32(31):4001-4005.
• [28] 陈洁，陈深侠，凌罗亚，等.国产麻疹流行性腮腺炎风疹联合疫苗初免效果及免疫程序探讨[J].中国计划免疫，2006,12(3):215-217.
• [29] WHO.Summary of WHO position papers-recommendations for routine immunization[EB/OL].(2020-09-19) [2021-03-03].https://www.who.int/immunization/policy/Immunization_routine_table1.pdf?ua=1,2019.
• [30] WHO.Measles vaccines:WHO position paper,April 2017-recommendations[J].Vaccine,2019,37(2):219-222.
• [31] GAGNEUR A,PINQUIER D,QUACH C.Immunization of preterm infants[J].Human Vaccines & Immunotherapeutics,2015,11(11):2556-2563.
• [32] ESPOSITO S,SERRA D,GUALTIERI L,et al.Vaccines and preterm neonates:why,when,and with what[J].Early Human Development,2009,85(Suppl 10):43-45.
• [33] SAARI TN,Diseases American Academy of Pediatrics Committee on Infectious.Immunization of preterm and low birth weight infants.American Academy of Pediatrics Committee on Infectious Diseases[J].Pediatrics,2003,112(1 Pt 1):193-198.
• [34] Anon.Update on timing of hepatitis B vaccination for premature infants and for children with lapsed immunization.American Academy of Pediatrics Committee on Infectious Diseases[J].Pediatrics,1994,94(3):403-404.
• [35] American Academy of Pediatrics.Red Book:2018 report of the Committee on Infectious Diseases[M].31st edition.Itasca IL:American Academy of Pediatrics,2018:67-68.
• [36] Australian Technical Advisory Group on Immunisation (ATAGI).The Australian immunisation handbook (2017 update)[M].10th edition.Canberra:Australian Government Department of Health,2017.
• [37] SALISBURY D,RAMSAY M.The Green Book,Chapter 7:Immunisation of individuals with underlying medical conditions[EB/OL].(2021-01-15) [2021-03-03].https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/857279/Greenbook_chapter_7_Immunsing_immunosupressed.pdf.
• [38] 向莉，申昆玲.儿童常见过敏性疾病诊疗概述[J].中国医学前沿杂志(电子版),2013,5(8):1-6.
• [39] KELSO JM.Update on vaccination guidelines for allergic children[J].Expert Review of Vaccines,2009,8(11):1541-1546.
• [40] 中华医学会儿科学分会免疫学组.免疫功能异常患儿的预防接种专家共识(试行稿):原发性免疫缺陷病[J].中华儿科杂志，2015,53(12):898-902.
• [41] RUBIN GL,LEVIN JM,LJUNGMAN P,et al.2013 IDSA clinical practice guideline for vaccination of the immunocompromised host[J].Clinical Infectious Diseases,2014,58(3):44-100.
• [42] PRINCIPI N,ESPOSITO S.Vaccine use in primary immunodeficiency disorders[J].Vaccine,2014,32(30):3725-3731.
• [43] 杨永弘.儿科疫苗学[J].北京：北京科学技术出版社，2013:91.
• [44] PLOTKIN SA,ORENSTEIN WA,PAUL A,et al.Vaccines[M].6th edition.Philadelphia:Elsevier,2008:1254.
• [45] WU JF,CHIANG BL,CHEN HL,et al.Impaired T-lymphocyte proliferation function in biliary atresia patients with chronic cholestatic jaundice after a Kasai operation[J].Pediatric Research,2006,60(5):602-606.
• [46] KUMAR M,HERRERA JL.Importance of hepatitis vaccination in patients with chronic liver disease[J].Southern Medical Journal,2010,103(12):1223-1231.
• [47] WU JF,NI YH,CHEN HL,et al.Inadequate humoral immunogenicity to recombinant hepatitis B virus vaccine in biliary atresia children[J].Pediatric Research,2008,64(1):100-104.
• [48] WU JF,NI YH,CHEN HL,et al.Humoral immunogenicity to measles,rubella,and varicella-zoster vaccines in biliary atresia children[J].Vaccine,2009,27(21):2812-2815.
• [49] 王卫平，毛萌，李廷玉，等.儿科学[M].第8版.北京：人民卫生出版社，2017:119-122.
• [50] 中华医学会儿科学分会新生儿学组.新生儿高胆红素血症诊断和治疗专家共识[J].中华儿科杂志，2014,52(10):745-748.
• [51] 中华医学会儿科学分会神经学组.热性惊厥诊断治疗与管理专家共识(2017实用版)[J].中华实用儿科临床杂志，2017,32(18):1379-1382.
• [52] CENDES F,SANKAR R.Vaccinations and febrile seizures[J].Epilepsia,2011,52(Suppl 3):23-25.
• [53] SUN Y,CHRISTENSEN J,HVIID A,et al.Risk of febrile seizures and epilepsy after vaccination with diphtheria,tetanus,acellular pertussis,inactivated poliovirus,and Haemophilus influenzae type b[J].JAMA,2012,307(8):823-831.
• [54] MCLEAN HQ,FIEBELKORN AP,TEMTE JL,et al.Prevention of measles,rubella,congenital rubella syndrome,and mumps,2013:summary recommendations of the Advisory Committee on Immunization Practices (ACIP)[J].MMWR.Recommendations and Reports,2013,62(4):1-34.
• [55] 吴兆芳，姜琨，刘文华，等.脑性瘫痪患儿免疫规划疫苗接种率调查研究[J].中国全科医学，2012,15(36):4209-4212.
• [56] 卫生部.关于印发《新生儿疾病筛查技术规范(2010年版)》的通知[Z].2010-11-10.
• [57] 卫生部.新生儿疾病筛查管理办法[S].2009-02-16.
• [58] KINGSLEY JD,VARMAN M,CHATTERJEE A,et al.Immunizations for patients with metabolic disorders[J].Pediatrics,2006,118(2):460-470.
• [59] MENNI F,CHIARELLI G,SABATINI C,et al.Vaccination in children with inborn errors of metabolism[J].Vaccine,2012,30(50):7161-7164.
• [60] ESPOSITO S,SALVINI F,MENNI F,et al.Preliminary data on immunogenicity,safety and tolerability of trivalent inactivated influenza vaccine in children with inborn errors of metabolism at risk of decompensation[J].Vaccine,2013,31(45):5149-5151.
• [61] 卫生部.关于印发《孕前保健服务工作规范(试行)》的通知[Z].2007-02-06.